Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Attovia Therapeutics, Inc.
Attovia Therapeutics Announces First Participant Dosed in First-in-Human Phase 1 Study of ATTO-1310, its Novel Half-life Extended Anti-IL-31 ATTOBODY for the Treatment of Chronic Pruritus
January 23, 2025
From
Attovia Therapeutics, Inc.
Via
GlobeNewswire
Attovia Therapeutics Appoints Chief Financial Officer
October 15, 2024
From
Attovia Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CNTB
Attovia Therapeutics Announces Election of Mitchell Gold and Angie You to Board of Directors
July 09, 2024
From
Attovia Therapeutics, Inc.
Via
GlobeNewswire
Tickers
ORIC
Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alternatives
May 09, 2024
From
Attovia Therapeutics, Inc.
Via
GlobeNewswire
Attovia Enhances Clinical and Development Expertise with Appointment of Chief Medical Officer and Clinical and Scientific Advisory Boards
March 26, 2024
From
Attovia Therapeutics, Inc.
Via
GlobeNewswire
Attovia Announces Second Tranche Closing of $60 Million Series A Financing and Highlights Progress Building a Best-in-Class Pipeline Leveraging the Attobody™ Platform
February 08, 2024
From
Attovia Therapeutics, Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.